GlassScriptPhysician profile
Haley N Texley
NPI 1174153027
$318.15
in general payments reported to CMS, 2019-2025
11 companies · $112 in 2025
The $112 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $104 · 2022: $102 · 2025: $112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $51.48 | 2021-2022 | |
| Abbvie INC. | $42.62 | 2021-2022 | |
| Myovant Sciences INC. | $42.14 | 2021-2022 | |
| Sage Therapeutics, LLC | $39.95 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $35.04 | 2025 | |
| Supernus Pharmaceuticals, INC. | $22.20 | 2025 | Qelbree |
| Bayer Healthcare Pharmaceuticals INC. | $19.01 | 2021 | |
| Agile Therapeutics, INC. | $17.72 | 2021 | |
| Coopersurgical, INC. | $16.84 | 2022 | |
| Philips North America LLC | $16.02 | 2021 | |
| Sumitomo Pharma America, INC. | $15.13 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haley Texley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.